This map shows the geographic impact of C Lançon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Lançon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Lançon more than expected).
This network shows the impact of papers produced by C Lançon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Lançon. The network helps show where C Lançon may publish in the future.
Co-authorship network of co-authors of C Lançon
This figure shows the co-authorship network connecting the top 25 collaborators of C Lançon.
A scholar is included among the top collaborators of C Lançon based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with C Lançon. C Lançon is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Llorca, Pierre‐Michel, Guillaume Vaïva, & C Lançon. (2001). Supersensitivity psychosis in patients with schizophrenia after sudden olanzapine withdrawal.. PubMed. 46(1). 87–8.18 indexed citations
11.
Reine, G., et al.. (2000). [Psychometric properties of French version of the Calgary depression scale for schizophrenics (CDSS)].. PubMed. 26(1). 52–61.21 indexed citations
12.
Lançon, C, et al.. (2000). [Clozapine in the treatment of refractory rapid cycling bipolar disorder].. PubMed. 22(6). 468–9.5 indexed citations
13.
Llorca, Pierre‐Michel, et al.. (2000). [The concept of supersensitivity psychosis. The particular case of clozapine].. PubMed. 25(6). 638–44.4 indexed citations
Launois, R, et al.. (1998). [Cost of illness: an inextricable maze or an aid in decision making? The case of schizophrenia].. PubMed. 24(2). 83–99.5 indexed citations
16.
Lançon, C, David W. Bernard, & Thierry Bougerol. (1997). [Fluoxetine, akathisia and suicide].. PubMed. 23(3). 218–23.3 indexed citations
17.
Llorca, Pierre‐Michel, et al.. (1997). [Clinical effects of clozapine: effect on negative symptoms].. PubMed. 22(4). 287–92.1 indexed citations
18.
Lançon, C, et al.. (1997). [Psychometric properties of PANSS (Positive and Negative Syndrome Scale) in the French version in a sample of schizophrenic patients].. PubMed. 23(1). 1–9.25 indexed citations
19.
Bernard, David W., et al.. (1996). [Body weight changes under psychotropic treatment].. PubMed. 25(28). 1292–6.1 indexed citations
20.
Lançon, C, et al.. (1994). [Comparative efficacy of bromocriptine, carbamazepine and cyproheptadine with neuroleptics in 24 refractory chronic schizophrenic patients].. PubMed. 19(5). 565–71.3 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.